Competitive Landscape and CompleteNorth America Medication-Assisted Treatment (MAT) Market
- DataBridge Market004
- Aug 24, 2022
- 3 min read
The North America Medication-Assisted Treatment (MAT) Market a rate of CAGR of 9.7% in the forecast period 2022 to 2029
To bring about this report, primary and secondary research methodologies have been employed for a detailed study. Researchers and analysts have also estimated key milestones achieved by the North America Medication-Assisted Treatment (MAT) Market and associated them to the current market trends to give the readers a holistic picture of the market. This market document performs SWOT analysis of major key players of the industry based on strengths, weaknesses, opportunities and threats as well as the company’s internal & external environments. This North America Medication-Assisted Treatment (MAT) Market research report evaluates the current as well as future performance of the market, and also brand-new trends in the market. The market report is an important element which gains demand from all corners of the globe. It provides product overview and highlights of product and application segments of the global market including price, revenue, sales, sales growth rate, and market share by product. In this healthcare market report, a section for the competitive landscape of the key players operating in the global market has also been covered. Moreover, this industry report lists and studies the leading competitors, also provides the insights with strategic industry analysis of the key factors influencing the market dynamics.
Get the sample copy of Report here:
North America Medication-Assisted Treatment (MAT) Market Scope
The medication-assisted (MAT) treatment market is segmented on the basis of eight segments: type, products, drug type, and dosage form, route of administration, population type, end user and distribution channel. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Type
· Medication
· Therapy
On the basis of type the North America medication-assisted treatment (MAT) market is segmented into medication and therapy.
Products
· Buprenorphine and Naloxone
· Naltrexone
· Buprenorphine
· Methadone
· Naloxone
· Disulfiram
· Acamprosate
On the basis of products, the North America medication-assisted treatment (MAT) market is segmented into buprenorphine and naloxone, naltrexone, buprenorphine, methadone, naloxone, disulfiram and acamprosate.
Drug Type
· Generics
· Branded
On the basis of drug type, the North America medication-assisted treatment (MAT) market is segmented into generics and branded.
Dosage Form
· Immediate Release
· Extended Release
On the basis of dosage form, the North America medication-assisted treatment (MAT) market is segmented into immediate release and extended release.
Route of Administration
· Oral
· Parenteral
· Others
On the basis of route of administration, the North America medication-assisted treatment (MAT) market is segmented into oral, parenteral and others.
Population Type
· Adults
· Teenage
On the basis of population type, the North America medication-assisted treatment (MAT) market is segmented into adults and teenage.
End User
· Rehabilitation Clinics
· Hospitals
· Specialty Centers
· Homecare
· Others
On the basis of end user, the North America medication-assisted treatment (MAT) market is segmented into rehabilitation clinics, hospitals, speciality centers, homecare and others.
Distribution Channel
· Hospital Pharmacy
· Direct Tender
· Retail Pharmacy
· Online Pharmacy
· Others
Medication-Assisted (MAT) Treatment Market Regional Analysis/Insights
The North America medication-assisted treatment (MAT) market is analysed and market size insights and trends are provided by regions, product type, type, application, workflow, end user and distribution channel as referenced above.
The countries covered in the medication-assisted (MAT) treatment market report are U.S., Canada and Mexico.
The U.S. is expected to dominate the market due to a rise in opioid dependency on medication, healthcare expenditure, and pharmaceutical companies.
Competitive Landscape and Medication-Assisted (MAT) Treatment Market Share Analysis
The North America medication-assisted treatment (MAT) market competitive landscape provides details of a competitor. Details include company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, the North America presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width, and breadth, application dominance. The above data points provided are only related to the companies' focus on the medication-assisted (MAT) treatment market.
Some major players operating in the medication-assisted (MAT) treatment market are Indivior PLC, Orexo US Inc (a subsidiary of Orexo AB), Recovery Centers of America, Alkermes. Sun Pharmaceutical Industries Ltd., Purdue Pharma L.P., Taj Pharmaceuticals Limited, Lannett, Hikma Pharmaceuticals PLC, Pfizer Inc., Pinnacle Treatment Center, American Addiction Centers, Adamis Pharmaceuticals Corporation, Glenmark Pharmaceutical Inc. Viatris Inc., Mallinckrodt, Alvogen, VistaPharm, Inc., Amneal Pharmaceuticals LLC. Titan Pharmaceuticals, Inc.
Get Full Access of reports @
MAJOR TOC OF THE REPORT
Chapter One: Introduction
Chapter Two: Market Segmentation
Chapter Three: Market Overview
Chapter Four: Executive Summary
Chapter : Medication-Assisted Treatment (MAT) Market
Get TOC Details
Browse Related Reports@
About Us:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market
Contact:
Data Bridge Market Research
Tel: +1-888-387-2818
Comments